Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

"Physiological spaces and multicompartmental pharmacokinetic models": Fundamentals that pharmacokinetics textbooks do not tell you

Yim DS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clearance

Holford N, Yim DS

This tutorial deals with basic concepts of clearance, the most important parameter in pharmacokinetics but often challenging for students in clinical pharmacology. Its relationships with dose, concentration and elimination rate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Physiological spaces and multicompartmental pharmacokinetic models

Atkinson A

The idea of body compartments has its origins in physiology and antedates their use in both physiologically-based predictive pharmacokinetic models and in the simpler compartmental models used to analyze pharmacokinetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetics and bioequivalence of two different 20 mg olmesartan tablets: A randomized, single-dose, two-period crossover study in healthy Korean male volunteers

Lee J, Kim A, Yu KS, Chung JY, Yim SV, Kim BH

Olmesartan is an angiotensin receptor blocker (ARB) and is widely used in clinical practice to treat hypertension. To compare the pharmacokinetic (PK) parameters and tolerability of two oral formulations of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Validation of a method for the determination of thiocyanate in human plasma by UV/VIS spectrophotometry and application to a Phase I clinical trial of GDC-0425

Shin YG, Meijering , van Heuveln FH, Wieling J, Halladay J, Sahasranaman S, Hop CE

The development and validation of a method for the determination of concentrations of thiocyanate in human plasma are described here. A modified colorimetric method of Bowler was used with the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A quantitative approach for cardiovascular safety evaluation of a generic drug

Son M, Kim Y, Chae DW, Park K

In generic drug development, comparative pharmacokinetic (PK) studies are conducted to assess equivalence in pharmacokinetics and safety profiles between test and reference formulations. However, there is no established quantitative approach...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Population pharmacokinetic analysis of the multiple peaks phenomenon in sumatriptan

Lee J, Lim MS, Seong SJ, Park SM, Gwon MR, Han S, Lee SM, Kim W, Yoon YR, Yoo HD

The objective of this study was to develop a population pharmacokinetic (PK) model for sumatriptan, which frequently shows an atypical absorption profile with multiple peaks. Sumatriptan, a selective agonist for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serious adverse events during clinical trial for pharmacokinetic interaction between telmisartan and chlorthalidone in healthy Korean subjects: A case report

Seong SJ, Yoon YR, Lim MS

Telmisartan is an angiotensin II receptor antagonist and chlorthalidone is a thiazide-like diuretics. In this study, we report serious adverse events (SAEs) during clinical trial for pharmacokinetic interaction between telmisartan...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr